Nosocomial acquisition and transmission of antibiotic-resistant Gram-negative organisms in the pediatric intensive care unit

Pediatric Infectious Disease Journal

Volumn 20, Issue 6, 2001, Pages 612-618

  Toltzis, Philip ^a,b,c   Blumer, Jeffrey L ^a,b  

^a Department of Pediatrics ^*

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Antibiotic resistance; Antibiotic utilization; Gram negative bacilli; Infection control; Intensive care

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; DISEASE TRANSMISSION; DRUG EXPOSURE; EPIDEMIC; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE; MODEL; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS, PEDIATRIC;

EID: 0034970422     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200106000-00013     Document Type: Review

References (77)

1. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
2. Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States: National Nosocomial Infections Surveillance System
3. Health and economic impacts of antimicrobial resistance
4. Changing pharyngeal bacterial flora of hospitalized patients: Emergence of Gram-negative bacilli
5. Factors predisposing to oropharyngeal colonization with Gram-negative bacilli in the aged
6. Sources of Gram-negative bacilli colonizing the tracheae of intubated patients
7. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
8. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics
9. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family Enterobacteriaceae
10. Nursery epidemic due to multiply-resistant Klebsiella pneumoniae: Epidemiologic setting and impact on perinatal health care delivery
11. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
12. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit
13. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility
14. Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients
15. Enteric colonization with antibiotic resistant bacteria in nurses working in intensive care units
16. Gram-negative bacilli as nontransient flora on the hands of hospital personnel
17. Pseudomonas in the sinks in an intensive care unit: Relation to patients
18. Relation of the inanimate hospital environment to endemic nosocomial infection
19. Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery
20. Epidemiology of endemic Pseudomonas aeruginosa: Why infection control efforts have failed
21. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance?
22. Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units
23. Molecular epidemiology of acquisition of ceftazidime-resistant Gram-negative bacilli in a nonoutbreak setting
24. Reasons for the emergence of antibiotic resistance
25. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the prevention of antimicrobial resistance: Guidelines for the prevention of antimicrobial resistance in hospitals
26. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals
27. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: A challenge to hospital leadership
28. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit
29. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
30. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms
31. Risk factors associated with the acquisition of amikacin-resistant Gram-negative bacilli in central New Jersey hospitals
32. Colonization with broad-spectrum cephalosporin-resistant Gram-negative bacilli in intensive care units during a nonoutbreak period: Prevalence, risk factors, and rate of infection
33. Imipenem-resistant Pseudomonas aeruginosa: Risk factors and antibiotic susceptibility patterns
34. Influence of amikacin as the primary aminoglycoside on bacterial isolates in the intensive care unit
35. An antibiotic policy to prevent emergence of resistant bacilli
36. Scheduled change of antibiotic classes: A strategy to decrease the incidence of ventilator-associated pneumonia
37. The emergence of bacterial resistance in hospitals: A need for continuous surveillance
38. Third generation cephalosporin-resistant Gram-negative bacilli in the feces of hospitalized children
39. Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: A historical cohort study
40. Use of pulsed-field gel electrophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit
41. Colonization with antibiotic-resistant Gram-negative organisms in a pediatric intensive care unit
42. Antibiotic restriction does not alter endemic colonization with resistant Gram-negative rods in a pediatric intensive care unit
43. Antimicrobial resistance rates among aerobic Gram-negative bacilli recovered from patients in intensive care units: Evaluation of a national postmarketing surveillance program
44. Antibiotic susceptibility in aerobic Gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study)
45. Epidemiologic typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units
46. Factors that predict preexisting colonization with antibiotic-resistant Gram-negative bacilli in patients admitted to a pediatric intensive care unit
47. Antimicrobial resistance in fecal flora: Longitudinal community-based surveillance of children from urban Mexico
48. High frequency of antimicrobial resistance in human fecal flora
49. Antimicrobial resistance of fecal aerobic Gram-negative bacilli in different age groups in a community
50. Antibiotic-resistant Gram-negative bacteria in the critical care setting
51. Postoperative Serratia marcescens wound infections traced to an out-of-hospital source
52. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: Did staff fingernails play a role in disease transmission?
53. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit
54. The population dynamics of antimicrobial chemotherapy
55. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs
56. From the cover: The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions
57. A computer-assisted management program for antibiotics and other antiinfective agents
58. Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory
59. Effects of requiring prior authorization for selected antimicrobials: Expenditures, susceptibilities, and clinical outcomes
60. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
61. Antibiotic resistance: Control strategies
62. A review of the role of antibiotic policies in the control of antibiotic resistance
63. Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants)
64. Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: Are beta-lactamase inhibitors of therapeutic value?
65. Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae
66. Cefepime: A fourth-generation parenteral cephalosporin
67. Carbapenem-hydrolyzing betalactamases
68. Acquired carbapenemases
69. DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
70. Rapid emergence of resistance to cefepime during treatment
71. Mechanisms of resistance to quinolones
72. Is "crop rotation" of antibiotics the solution to a "resistant" problem in the ICU?
73. Antibiotic cycling: Is it ready for prime time?
74. The microbial genetics of antibiotic cycling
75. Evaluating treatment protocols to prevent antibiotic resistance
76. Reduction of nosocomial infection during pediatric intensive care by protective isolation
77. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting